KIMBERLY KING: Open Payments
NPI 1215459136 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 18 payments from 9 companies in 2025. Trend: 2023 $783 · 2024 $158 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $99 |
| AtriCure, Inc. | 3 | $73 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $59 |
| Abbott Laboratories | 2 | $53 |
| Kerecis Limited | 2 | $44 |
| Smith+Nephew, Inc. | 1 | $29 |
| Amgen Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: LEQVIO, SYNERGY ABLATION SYSTEM, LifeVest, Kerecis SurgiClose, COLLAGENASE SANTYL, ENSITE, CARDIOMEMS, OTEZLA.
Industry payments across MS — which companies pay providers there.
